These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3089668

  • 1. Encainide disposition in patients with chronic cirrhosis.
    Bergstrand RH, Wang T, Roden DM, Avant GR, Sutton WW, Siddoway LA, Wolfenden H, Woosley RL, Wilkinson GR, Wood AJ.
    Clin Pharmacol Ther; 1986 Aug; 40(2):148-54. PubMed ID: 3089668
    [Abstract] [Full Text] [Related]

  • 2. Encainide disposition in patients with renal failure.
    Bergstrand RH, Wang T, Roden DM, Stone WJ, Wolfenden HT, Woosley RL, Wilkinson GR, Wood AJ.
    Clin Pharmacol Ther; 1986 Jul; 40(1):64-70. PubMed ID: 3087679
    [Abstract] [Full Text] [Related]

  • 3. The effect of diltiazem on the disposition of encainide and its active metabolites.
    Kazierad DJ, Lalonde RL, Hoon TJ, Mirvis DM, Bottorff MB.
    Clin Pharmacol Ther; 1989 Dec; 46(6):668-73. PubMed ID: 2513160
    [Abstract] [Full Text] [Related]

  • 4. Influence of genetic polymorphism on the metabolism and disposition of encainide in man.
    Wang T, Roden DM, Wolfenden HT, Woosley RL, Wood AJ, Wilkinson GR.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):605-11. PubMed ID: 6423808
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of encainide in patients with cirrhosis.
    Wensing G, Mönig H, Ohnhaus EE, Hoensch HP.
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):733-9. PubMed ID: 1909559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and metabolism of encainide.
    Jaillon P.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():561-5. PubMed ID: 2125833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacokinetics of encainide.
    Roden DM, Woosley RL.
    Clin Pharmacokinet; 1988 Mar; 14(3):141-7. PubMed ID: 3131058
    [Abstract] [Full Text] [Related]

  • 10. Co-inheritance of the polymorphic metabolism of encainide and debrisoquin.
    Woosley RL, Roden DM, Dai GH, Wang T, Altenbern D, Oates J, Wilkinson GR.
    Clin Pharmacol Ther; 1986 Mar; 39(3):282-7. PubMed ID: 3081292
    [Abstract] [Full Text] [Related]

  • 11. Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerations.
    McAllister CB, Wolfenden HT, Aslanian WS, Woosley RL, Wilkinson GR.
    Xenobiotica; 1986 May; 16(5):483-90. PubMed ID: 3090789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
    Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM.
    Circulation; 1988 Feb; 77(2):380-91. PubMed ID: 3123092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J, Klein H, Shanks RG, Bender F.
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM, Kates RE.
    Clin Pharmacokinet; 1984 Apr; 9(5):375-403. PubMed ID: 6437721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.